The Intestinal Forceps ecosystem encompasses a defined set of upstream, midstream, and downstream actors that collectively enable the delivery of surgical forceps to clinical settings. Upstream, raw‑material and component suppliers provide surgical‑grade stainless steel, polymers, and precision alloys that meet stringent biocompatibility criteria. Midstream, original equipment manufacturers (OEMs) convert these inputs into finished forceps, often leveraging specialized technology providers and system integrators that supply micro‑fabrication equipment and assemble the devices into sterile kits. Downstream, distributors and service providers manage logistics, regulatory compliance, and after‑sales support, while end users—hospitals, ambulatory surgical centers, and gastroenterology practices—apply the instruments in procedures. Value is created through material quality, manufacturing precision, and regulatory clearance, and captured via product pricing, service contracts, and repeat procurement cycles.